Dr. Gary Nakhuda

“I never tire of the sense of satisfaction that I get each time I do my small part to help build a family.”

Dr. Nakhuda's areas of expertise include polycystic ovarian syndrome, fertility preservation, recurrent pregnancy loss, and embryology laboratory technology. Preimplantation genetic testing (PGT) is another major focus, and he is currently studying the numerous reasons for implantation failure in apparently normal embryos. Dr. Nakhuda has served as the primary investigator in several clinical trials, and is dedicated to research and data analysis for quality control and improvement.


Dr. Nakhudais co-founder and co-director of Olive Fertility Centre.


He graduated from New York Medical College and spent the next 12 years at New York's Columbia University Medical Center. There, Dr. Nakhuda completed a residency in obstetrics and gynecology, which he followed up with a fellowship in reproductive endocrinology and infertility. He also served on the faculty of the Center for Women's Reproductive Care. During his time at Columbia University, he was active in both basic science and clinical research, publishing over 20 research articles and text book chapters. Dr. Nakhuda repeatedly received the “Patients Choice Award” for outstanding clinical care. Married to a BC native, he moved to Vancouver in 2011.


Dr. Nakhuda is board-certified in both ob-gyn and reproductive endocrinology and in infertility by the American Board of Obstetrics & Gynecology.


Harjee R, Chen J, Caudle J, Ouhibi N, Edsall S, Smrz J, Lardizabal J, Abdelghadir S, Nakhuda G. Oocyte cryopreservation: A nine year single-centre experience. J Obstet Gynaecol Can. 2022 Oct 19:S1701-2163(22)00672-7. doi: 10.1016/j.jogc.2022.10.006. Epub ahead of print. PMID: 36272695.


Tan J, Jing C, Zhang L, Lo J, Kan A, Nakhuda G. GnRH triggering may improve euploidy and live birth rate in hyper-responders: a retrospective cohort study. J Assist Reprod Genet. 2020 Aug;37(8):1939-1948. doi: 10.1007/s10815-020-01842-2. Epub 2020 Jun 13. PMID: 32533431; PMCID: PMC7468004.


Munné S, Kaplan B, Frattarelli JL, Child T, Nakhuda G, Shamma FN, Silverberg K, Kalista T, Handyside AH, Katz-Jaffe M, Wells D, Gordon T, Stock-Myer S, Willman S; STAR Study Group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019 Dec;112(6):1071-1079.e7. doi: 10.1016/j.fertnstert.2019.07.1346. Epub 2019 Sep 21. PMID: 31551155.

Butler R, Nakhuda G, Guimond C, Jing C, Lee N, Hitkari J, Tallon N, Taylor B, Yuzpe A. Analysis of PGT-M and PGT-SR outcomes at a Canadian fertility clinic. Prenat Diagn. 2019 Sep;39(10):866-870. doi: 10.1002/pd.5496. Epub 2019 Jun 26. PMID: 31169930.


Tan J, Kan A, Hitkari J, Taylor B, Tallon N, Warraich G, Yuzpe A, Nakhuda G. The role of the endometrial receptivity array (ERA) in patients who have failed euploid embryo transfers. J Assist Reprod Genet. 2018 Apr;35(4):683-692. doi: 10.1007/s10815-017-1112-2. Epub 2018 Jan 11. PMID: 29327111; PMCID: PMC5949105.


Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, Sauer MV,Anti-Müllerian Hormone Testing Is Useful for Individualization of Stimulation Protocols in Oocyte Donors. Reprod Biomed Online, February 2011 22 Suppl 1:S88-93. doi: 10.1016/S1472-6483(11)60014-X


Yu B, Douglas N, Ferin MJ, Nakhuda GS, Crew K, Lobo RA, Hershman DL,Changes in Markers of Ovarian Reserve and Endocrine Function in Young Women with Breast Cancer Undergoing Adjuvant Chemotherapy. Cancer, May 2010 116(9):2099-105. doi: 10.1002/cncr.25037


Nakhuda GS,The role of Mullerian Inhibiting Substance in Female Reproduction. Curr Opin Obstet Gyneco, June 2008 257-64. doi: 10.1097/GCO.0b013e3282fe99f2. Review


Nakhuda GS, Sauer MV, Wang JG, Ferin M, Lobo RA,Müllerian Inhibiting Substance Is an Accurate Marker of Ovarian Response in Women of Advanced Reproductive Age Undergoing IVF. Reprod Biomed Online, April 2007 14(4):450-4 


Nakhuda GS, Chu MC, Wang JG, Sauer MV, Lobo RA,Elevated Serum Müllerian-Inhibiting Substance may be a Marker for Ovarian Hyperstimulation Syndrome in Normal Women Undergoing In Vitro Fertilization. Fertil Steril, May 2006 85(5):1541-3. Epub 2006 Mar 29

Inclusion of all gender and sexually diverse people is an important value of Olive Fertility Centre. We are continuously striving to create an environment of compassionate belonging where all of the 2SLGBTQIA+ community are supported, valued and respected.

Olive Fertility Centre resides on the traditional, ancestral, and unceded territory of the xʷməθkwəy̓əm (Musqueam), Skwxwú7mesh (Squamish), and Tsleil-waututh Nations (Vancouver and Surrey clinics), of the Lekwungen people (Victoria clinic), of the syilx/Okanagan people (Kelowna clinic) and of the Lheidli T’enneh First Nation (Blossom Fertility clinic in Prince George).

© 2022-2024 Olive Fertility Centre. All Rights Reserved.